A 38-year-old woman with a 5-year history of temporal lobe epilepsy presents to neurology clinic with recurrent breakthrough seizures over the past 3 months. She reports that during these events, she experiences lip smacking and picking at her clothes for approximately 90 seconds, followed by 5-10 minutes of postictal confusion. She denies loss of consciousness during the episodes. She has been compliant with levetiracetam 2000 mg daily, and serum drug level is 18 mcg/mL (therapeutic range 12-46 mcg/mL). Brain MRI reveals left mesial temporal sclerosis. Which of the following best explains the mechanism of her inadequate seizure control despite therapeutic drug levels?
- A)Inadequate levetiracetam dosing; seizure threshold can only be lowered by increasing to maximum recommended dose of 3600 mg/day
- B)Development of secondary generalized epilepsy; focal seizures have progressed to generalized tonic-clonic seizures requiring dual antiepileptic therapy
- C)Pharmacoresistance due to increased P-glycoprotein expression at the blood-brain barrier reducing levetiracetam penetrationGABARITO
- D)Levetiracetam inefficacy for mesial temporal lobe seizures; lacosamide is the preferred agent for this specific epilepsy syndrome
- E)Postictal confusion indicating evolution to status epilepticus requiring immediate benzodiazepine monotherapy
Explicação
Pharmacoresistance (refractory epilepsy) is defined as failure to achieve seizure freedom despite adequate trials of two or more appropriately chosen antiepileptic drugs. In this case, the patient has therapeutic levetiracetam levels but continues to have brea... Ver explicação completa e trilha adaptativa →